Word

TRANSPIREBIO

Status

Pending

Status Code

730

Status Date

Wednesday, August 7, 2024

Serial Number

97803410

Mark Type

3

Filing Date

Tuesday, February 21, 2023

Published for Opposition

Tuesday, December 19, 2023

Trademark Owner History

Transpire Bio Inc - Owner At Publication

Classifications

5 Inhalers for medical use, sold filled with pharmaceutical preparations for the treatment of respiratory diseases and disorders and non-respiratory diseases and disorders; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers for medical use, sold filled with pharmaceutical preparations for the treatment of respiratory diseases and disorders; Inhalers for medical use, sold filled with pharmaceutical and bio-pharmaceutical preparations for the treatment of non-respiratory diseases and disorders

21 Inhalers, sold empty, not for medical or therapeutic use

10 Medical delivery system, apparatus, and instruments, namely, inhalers, sold empty, for the localized orally inhaled and systemic delivery of pharmaceutical preparations via orally inhaled route; Medical delivery system, apparatus, and instruments, namely, inhalers and nebulizers for medical use, sold empty, for facilitating the delivery of biological formulations, monoclonal antibodies, organic small molecule formulations, inorganic molecules formulations, peptides, proteins, oligonucleotides, RNA, DNA, vaccines, radiopharmaceuticals and nutraceuticals and combinations thereof; Medical delivery system, apparatus, and instruments, namely, inhalers for medical use, sold empty; Medical delivery system and apparatus for facilitating the inhalation of pharmaceutical preparations; Inhalers for medical use, sold empty; drug delivery devices sold empty, namely, inhalers

The mark consists of the wording "TRANSPIREBIO" with a curved line above the letters "REBI" and a curved line below the letters "IREB".
TRANSPIRE BIO
Color is not claimed as a feature of the mark.

Trademark Events

Feb 24, 2023

New Application Entered

Mar 10, 2023

New Application Office Supplied Data Entered

Mar 11, 2023

Notice Of Design Search Code E-Mailed

Oct 24, 2023

Assigned To Examiner

Oct 30, 2023

Examiners Amendment -Written

Oct 30, 2023

Examiners Amendment E-Mailed

Oct 30, 2023

Notification Of Examiners Amendment E-Mailed

Oct 30, 2023

Examiner's Amendment Entered

Nov 14, 2023

Examiners Amendment -Written

Nov 14, 2023

Examiners Amendment E-Mailed

Nov 14, 2023

Notification Of Examiners Amendment E-Mailed

Nov 14, 2023

Examiner's Amendment Entered

Nov 14, 2023

Approved For Pub - Principal Register

Nov 29, 2023

Notification Of Notice Of Publication E-Mailed

Dec 19, 2023

Published For Opposition

Dec 19, 2023

Official Gazette Publication Confirmation E-Mailed

Aug 7, 2024

Sou Teas Extension Received

Aug 7, 2024

Notice Of Approval Of Extension Request E-Mailed

Aug 7, 2024

Sou Extension 1 Granted

Aug 7, 2024

Sou Extension 1 Filed

Feb 13, 2024

Noa E-Mailed - Sou Required From Applicant